Results 11 to 20 of about 23,180 (193)

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing. [PDF]

Clin Pharmacol Ther
Post‐kala‐azar dermal leishmaniasis (PKDL) involves a high macrophage burden in which the Leishmania parasites reside. Liposomal amphotericin B (LAmB) plays a key role in the treatment of PKDL. The mononuclear phagocyte system (MPS) is crucial in the distribution of liposomal drugs as well as the leishmaniasis pathophysiology.
Chu WY, Singh OP, Sundar S, Mondal D, Pandey K, Das P, Roseboom IC, Raja S, Torres A, Carrillo E, Huitema ADR, Alves F, Dorlo TPC.   +12 more
europepmc   +2 more sources

Therapeutic Drug Monitoring of Amphotericin-B in Plasma and Peritoneal Fluid of Pediatric Patients after Liver Transplantation: A Case Series

Antibiotics, 2022
Fungal infections represent a serious complication during the post-liver transplantation period. Abdominal infections can occur following pre-existing colonization, surgical procedures, and permanence of abdominal tubes.
Francesca Tortora, Luigi Dei Giudici, Raffaele Simeoli, Fabrizio Chiusolo, Sara Cairoli, Paola Bernaschi, Roberto Bianchi, Sergio Giuseppe Picardo, Carlo Dionisi Vici, Bianca Maria Goffredo   +9 more
doaj   +1 more source

Case report: Reversible encephalopathy associated with liposomal amphotericin B in a patient with cryptococcal meningitis

Frontiers in Neurology, 2022
Liposomal amphotericin B (L-AMB) is an anti-fungus medicine that has fewer side effects than traditional amphotericin B (AMB). Neurotoxicity of L-AMB has rarely been observed, and only one case of leukoencephalopathy during intravenous L-AMB has been ...
Si Luo, Han Wen, Meihong Zhou, Chengsi Wu, Daojun Hong   +4 more
doaj   +1 more source

Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?

Allergy, Asthma & Clinical Immunology, 2021
Allergic reaction to liposomal amphotericin B is rare. We report a case of cardiac arrest in a 64-year-old woman following liposomal amphotericin B infusion, requiring resuscitation.
George P. Drewett, Ana Copaescu, Joseph DeLuca, Natasha E. Holmes, Jason A. Trubiano   +4 more
doaj   +1 more source

Disseminated Histoplasmosis in HIV-Infected Patients: A Description of 34 Years of Clinical and Therapeutic Practice

Journal of Fungi, 2020
Disseminated histoplasmosis is the main AIDS-defining infection of French Guiana. We aim to describe our therapeutic experience for 349 patients with disseminated histoplasmosis between 1 January 1981 and 10 January 2014 in French Guiana.
Mathieu Nacher, Audrey Valdes, Antoine Adenis, Romain Blaizot, Philippe Abboud, Magalie Demar, Félix Djossou, Loïc Epelboin, Caroline Misslin, Balthazar Ntab, Kinan Drak Alsibai, Pierre Couppié   +11 more
doaj   +1 more source

Successful treatment of invasive tracheobronchial pulmonary aspergillosis with venovenous extracorporeal membrane oxygenation and combined systemic, intratracheal instillation of liposomal amphotericin B: a case report

Journal of Medical Case Reports, 2022
Background Invasive pulmonary Aspergillus and invasive bronchial aspergillosis is a life-threatening opportunistic fungal infection that predominantly affects immunocompromised hosts.
Shuku Sato, Wataru Kamata, Kiyomitsu Fukaguchi, Shun Tsunoda, Tadashi Kamio, Hiroshi Koyama, Hideyasu Sugimoto, Yotaro Tamai   +7 more
doaj   +1 more source

Drug-induced hypersensitivity syndrome by liposomal amphotericin-B: a case report [PDF]

, 2015
BACKGROUND: Liposomal amphotericin-B (Ambisome(®)) is widely used antifungal drug for treatments of invasive fungal infections. The use of liposomal amphotericin-B is increasing in medical setting because of its tolerability and potent antifungal ...
Hideo Kato, Hiroshige Mikamo, Jun Hirai, Katsuhiko Matsuura, Mao Hagihara, Yuka Yamagishi, Yukihiro Hamada, Yusuke Koizumi   +7 more
core   +1 more source

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India [PDF]

, 2011
Reports on treatment outcomes of visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection in India are lacking. To our knowledge, none have studied the efficacy of liposomal amphotericin B in VL-HIV coinfection.
Alvar, Bachani, Berman, Bern, Bora, Braitstein, C. Ferreyra, D. Remartinez, G. Mitra, Hurissa, Ikomi, J. van Griensven, K. Pandey, L. Flevaud, Lin, Lyons, M. Pece, Mathur, N. Kumar, N. Verma, P. Das, P. K. Sinha, P. Kumar, P. P. Palma, Pintado, R. Kumar, R. Mahajan, Redhu, Sinha, Sinha, Sundar, Sundar, ter Horst, Thakur, van Griensven   +34 more
core   +2 more sources

Drug resistance and treatment failure in leishmaniasis: A 21st century challenge [PDF]

, 2017
Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment failure is an increasing problem.
Alicia Ponte-Sucre, Andrew W Pountain, Barbara Papadopoulou, Francisco Gamarro, Jean-Claude Dujardin, Michael P Barrett, Raquel García-Hernández, Rogelio López-Vélez, Roy Mwenechanya   +8 more
core   +13 more sources

Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever [PDF]

, 2002
Background Patients with neutropenia and persistent fever are often treated empirically with amphotericin B or liposomal amphotericin B to prevent invasive fungal infections.
Donowitz, Gerald, Greenberg, Richard, Lazarus, Hillard M., Lee, Jeanette, Pappas, Peter, Petersen, Finn, Raffalli, John, Stiff, Patric, Walsh, Thomas J., Winston, Drew J., Yanovich, Saul   +10 more
core   +2 more sources